NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 58.00

+3.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: zax	11/8/2017 11:53:52 PM
	of 507

30.30 +3.46 (+12.89%) Nektar (NKTR) Q3 Earnings & Sales Surpass, Sales View Up Zacks Equity Research finance.yahoo.com Nektar Therapeutics’ NKTR shares increased more than 10% on Nov 7 after reporting better-than-expected third-quarter results with both earnings and sales surpassing estimates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next